ATC Abstracts

American Transplant Congress abstracts

2018 American Transplant Congress » Poster Session C: Kidney Chronic Antibody Mediated Rejection

Date: Monday, June 4, 2018

Time: 6:00pm-7:00pm

Location: Hall 4EF

Session Type: Poster Session

Meeting: 2018 American Transplant Congress

6:00pm-7:00pm
“Majority Rules”: A Method to Reduce Variability in Diagnosing Antibody Mediated Rejection in Renal Allograft Biopsies Using Banff 2013

B. Smith,1 L. Cornell,1 M. Smith,2 C. Cortese,3 X. Geiger,3 C. Schinstock,1 W. Kremers,1 M. Stegall.1

6:00pm-7:00pm
Chronic Antibody Mediated Rejection in Renal Allografts Shows RNA Transcript Patterns That Evolve with Stage

A. Rosales,1 B. Adam,2 M. Mengel,2 T. Oura,1 M. Matsunami,1 T. Kawai,1 A. Cosimi,1 R. Smith,1 R. Colvin.1

6:00pm-7:00pm
De Novo DSA against Third Party Extension Vessels Used in Kidney and Pancreas Transplantation

N. Garg, T. Ellis, R. Redfield, S. Parajuli, B. Astor, A. Djamali, D. Mandelbrot.

6:00pm-7:00pm
De Novo Donor Specific Antibodies in Pediatric Kidney Transplant Recipients Are Highly Responsive to Therapy

V. Sigurjonsdottir, P. Grimm.

6:00pm-7:00pm
FSGS Pattern with Podocyte Proliferation and Heavy Proteinuria Combined Late Antibody Mediated Rejection of Renal Allograft: Collapsing Glomerulopathy or Transplant Podocytopathy?

J. Wen, M. Zhang, F. Xu, J. Chen, D. Cheng, X. Ni, X. Li.

6:00pm-7:00pm
Failure to Remove De Novo Donor-Specific HLA Antibodies is Influenced by Antibody Properties and Identifies Kidney Recipients with Late Antibody-Mediated Rejection Destined to Graft Loss

A. Nocera,1 M. Cioni,1 A. Tagliamacco,2 S. Basso,3 A. Innocente,4 I. Fontana,5 A. Magnasco,1 A. Trivelli,1 A. Gurrado,3 M. Ramondetta,4 S. Boghen,3 L. Catenacci,3 E. Verrina,1 G. Garibotto,2 G. Ghiggeri,1 M. Cardillo,4 F. Ginevri,1 P. Comoli.3

6:00pm-7:00pm
Functional Fc Gamma Receptor Gene Polymorphisms and Donor-Specific Antibody-Triggered Transplant Injury

M-.L. Arnold,1 A. Kainz,2 F. Eskandary,2 N. Kozakowski,3 M. Wahrmann,2 H. Haslacher,4 R. Oberbauer,2 A. Heilos,5 B. Spriewald,6 L. Hidalgo,7 P. Halloran,8 G. Bohmig.2

6:00pm-7:00pm
Genetic Risk Factors of Post-Transplant Thrombocytopenia in Kidney Allograft Recipients

D. Min,1 Y. Chang,2 T. Shah.3

6:00pm-7:00pm
Intravenous Immunoglobulins and Methylprednisolone Stabilizes Renal Allograft Function in the Majority of Patients with C-aABMR

K. Sablik, M. Clahsen-van Groningen, C. Looman, J. Damman, M. van Agteren, M. Betjes.

6:00pm-7:00pm
Long Term Outcomes of Renal Allografts with De Novo DSA in the Setting of Stable Graft Function versus Acute Rejection

R. Knight,1 D. Nguyen,2 E. Graviss,2 T. Eagar,2 S. Kuten,3 S. Patel,3 L. Moore,1 A. Gaber.1

6:00pm-7:00pm
Lower Incidence of De Novo Donor-Specific Antibodies against HLA-DR in ABO-Incompatible Renal Transplantation

M. Okada,1 K. Futamura,1 T. Hiramitsu,1 M. Tsujita,1 N. Goto,1 S. Narumi,1 Y. Watarai,1 K. Iwasaki,2 T. Kobayashi.2

6:00pm-7:00pm
Molecular Assessment of Post-Transplant Glomerular Disease Comparing to Transplant Glomerulopathy

E. Akalin,1 M. e Silva,2 Y. Bao,1 V. Bontha,3 M. Ajaimy,1 V. Mas,3 P. [Oacute] Broin.2

6:00pm-7:00pm
NKG2C+CD57+ NK (G2C+57+) Cells Expanded by CMV Infection Are Highly Responsive to Allo-Antibody (Ab)-Mediated NK Cell Stimulation

B. Shin,1 D. Puliyanda,2 H. Pizzo,2 S. Jordan,2 M. Toyoda.1

6:00pm-7:00pm
Patients with C-aABMR and V-Lesions in Their Renal Transplant Biopsy Have a Superior Response to Treatment

K. Sablik, M. Clahsen-van Groningen, C. Looman, M. Betjes.

6:00pm-7:00pm
Pre-Transplant versus De Novo Donor Specific Antibodies: Differences in Clinical Outcomes and Antibody Mediated Rejection

M. Ajaimy, N. Hayde, A. Colovai, E. Akalin.

6:00pm-7:00pm
Prediction of Renal Allograft Chronic Rejection Using a Model Based on Contrast EnhancedUltrasonography

C. Yang,1 S. Wu,3 T. Zhu,1 W. He.2

6:00pm-7:00pm
RNA Expression Profiling of Renal Allografts in a Non-Human Primate Identifies Inflammation as a Risk Factor in Chronic Antibody Mediated Rejection

R. Smith,1 B. Adam,2 A. Rosales,1 M. Matsunami,3 T. Oura,3 B. Cosimi,3 T. Kawai,3 M. Mengel,2 R. Colviin.1

6:00pm-7:00pm
Renal Allograft Cortical Perfusion Quantification by 3D-Arterial Spin Labeling Could Be Used to Identify Subclinical Antibody-Mediated Rejection

W. Wang,1 J. Wen,2 F. Xu,2 Y. Yu,3 L. Zhang,3 Z. Liu.2

6:00pm-7:00pm
Scoring Transplant Glomerulopathy Using Morphometry: Correlation with Banff Criteria

M. Morales, A. Denic, W. Park, B. Smith, M. Alexander, M. Stegall.

6:00pm-7:00pm
Searching for Recipient-HLA Class II and Donor-HLA-Derived Peptide Complexes Inducing Protective Effect against De Novo Donor-Specific HLA Antibodies Formation in Kidney Transplantation

T. Tomosugi,1 K. Iwasaki,1 M. Okumura,1 Y. Matsuoka,1 K. Horimi,1 M. Okada,2 Y. Watarai,2 T. Kobayashi.1

6:00pm-7:00pm
Sub-Clinical Acute Rejection (subAR) Detected by Both Surveillance Biopsy (SBx) and a Peripheral Blood Molecular Biomarker Correlates with De Novo Donor Specific Antibody (dnDSA) Following Kidney Transplant (KT)

R. Heilman,1 J. Friedewald,2 K. Kurian,5 T. Whisemant,5 E. Poggio,3 C. Marsh,5 P. Baliga,7 N. Bridges,4 J. Odim,4 M. Brown,4 D. Ikle,3 B. Armstrong,3 L. Zhao,2 D. Salomon,5 M. Abecassis.2

6:00pm-7:00pm
Two Similar Risk Models Identify Different Patients for Graft Loss: Implications for Clinical Trials in DSA+ Kidney Transplant Recipients

A. Bentall, B. Smith, W. Park, C. Schinstock, M. Stegall.

6:00pm-7:00pm
Urinary Proteomic Biomarkers for Prediction of Chronic Antibody-Mediated Rejection in Kidney Transplant Recipients

H. Jung,1 K. Jeong,1 J-.H. Lim,1 J. Choi,1 J-.H. Cho,1 S-.H. Park,1 Y-.L. Kim,1 C-.H. Lee,2 M-.C. Baek,2 B. Chung,3 S-.H. Lee,4 C-.D. Kim.1

« View all sessions from the 2018 American Transplant Congress